Information for "Neutrophiltolymphocyte ratio in conjunction with PDL1 as well as lactate dehydrogenase as biomarkers for top PDL1 nonsmall cellular carcinoma of the lung helped by firstline pembrolizumab"
From EECH Central
Basic information
| Display title | Neutrophiltolymphocyte ratio in conjunction with PDL1 as well as lactate dehydrogenase as biomarkers for top PDL1 nonsmall cellular carcinoma of the lung helped by firstline pembrolizumab |
| Default sort key | Neutrophiltolymphocyte ratio in conjunction with PDL1 as well as lactate dehydrogenase as biomarkers for top PDL1 nonsmall cellular carcinoma of the lung helped by firstline pembrolizumab |
| Page length (in bytes) | 3,525 |
| Page ID | 1425557 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Milepoison3 (Talk | contribs) |
| Date of page creation | 08:44, 1 May 2024 |
| Latest editor | Milepoison3 (Talk | contribs) |
| Date of latest edit | 08:44, 1 May 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
